COVID-19 vaccine
COVID-19 vaccine is a biological therapy with 51 clinical trials. Currently 9 active trials ongoing. Historical success rate of 90.5%.
Success Metrics
Based on 19 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
3
Mid Stage
6
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
82.6%
19 of 23 finished
17.4%
4 ended early
9
trials recruiting
51
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
COVID-19 Vaccine Response in Chronic Respiratory Conditions
A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza
Immunosuppression and COVID-19 Boosters
SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer
Effects of Oral Iron Supplementation on Vaccine Response in Iron Deficient Kenyan Women
Clinical Trials (51)
COVID-19 Vaccine Response in Chronic Respiratory Conditions
A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza
Immunosuppression and COVID-19 Boosters
SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer
Effects of Oral Iron Supplementation on Vaccine Response in Iron Deficient Kenyan Women
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Combined Modified RNA Vaccine Candidate Against COVID-19 and Influenza.
COVID-19 Pregnancy Related Immunological, Clinical and Epidemiological Factors and Perinatal Outcomes
A Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 (Influenza and COVID-19) Vaccine in Adults ≥18 to <65 Years of Age
COVID-19 Vaccines International Pregnancy Exposure Registry
Covid-19 and Influenza Oral Vaccine Study
A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People
Investigation of the Effects of Dietary Nitrate and Sex on COVID-19 Vaccine Induced Vascular Dysfunction in Healthy Men and Women (DiNOVasc-COVID-19)
Determining the Relationship Between Gut Microbiota and Immune Response to Influenza or COVID-19 Vaccine
A Study of mRNA-1083 (SARS-CoV-2 and Influenza) Vaccine in Healthy Adult Participants, ≥50 Years of Age
Evaluating the Immune Response to COVID19 Vaccination in Immunodeficient Patients
Exercise and COVID-19 Viral T-cell Immunity
COVID-19 Vaccine Response in Sickle Cell Disease
Post COVID-19 Vaccination Analysis in Healthcare Worker Recipients
Comparison of the Immune Response to Natural COVID-19 Infection and Vaccination
Vaccine Observation to Include All Communities for Equitable Science
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 51